Free Trial

CollPlant Biotechnologies (CLGN) News Today

CollPlant Biotechnologies logo
$4.23 +0.04 (+0.95%)
(As of 11/20/2024 ET)
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 9,900 shares, a growth of 5.3% from the August 31st total of 9,400 shares. Based on an average trading volume of 12,200 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the shares of the stock are sold short.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 9,400 shares, an increase of 11.9% from the August 15th total of 8,400 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 12,800 shares, the short-interest ratio is currently 0.7 days.
CollPlant Biotechnologies Ltd. stock logo
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN)
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - HC Wainwright lifted their Q3 2024 earnings per share estimates for shares of CollPlant Biotechnologies in a report released on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.37)
CollPlant Biotechnologies Ltd. stock logo
HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Free Report) - Stock analysts at HC Wainwright cut their FY2027 earnings per share estimates for CollPlant Biotechnologies in a research report issued to clients and investors on Wednesday, August 21st. HC Wainwright analyst S. Ramakanth now anticipat
CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies (NASDAQ:CLGN) Upgraded at EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I raised CollPlant Biotechnologies to a "strong-buy" rating in a report on Monday.
Collplant Biotechnologies Ltd (CLGN)
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Increase in Short Interest
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, an increase of 533.3% from the June 30th total of 600 shares. Based on an average trading volume of 8,000 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company's stock are short sold.
CollPlant Biotechnologies Ltd. stock logo
Short Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Drops By 64.7%
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 600 shares, a decrease of 64.7% from the June 15th total of 1,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 7,600 shares, the days-to-cover ratio is currently 0.1 days.
CollPlant Biotechnologies Ltd. stock logo
Short Interest in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Declines By 26.1%
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,700 shares, a drop of 26.1% from the May 31st total of 2,300 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 7,200 shares, the short-interest ratio is currently 0.2 days.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Down 66.2% in May
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,300 shares, a decline of 66.2% from the May 15th total of 6,800 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 6,200 shares, the short-interest ratio is currently 0.4 days.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Drop in Short Interest
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,800 shares, a decline of 34.8% from the April 15th total of 8,900 shares. Based on an average daily trading volume, of 6,900 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the company's shares are short sold.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 33.3% in March
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 10,800 shares, an increase of 33.3% from the March 15th total of 8,100 shares. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is currently 1.3 days. Approximately 0.1% of the shares of the company are short sold.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies (NASDAQ:CLGN) Rating Reiterated by HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $11.00 price objective on shares of CollPlant Biotechnologies in a report on Friday.
CollPlant Biotechnologies FY23 Net Loss Narrows
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Significant Decrease in Short Interest
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 8,100 shares, a drop of 13.8% from the February 29th total of 9,400 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 0.7 days. Approximately 0.1% of the company's stock are short sold.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday
CollPlant Biotechnologies (NASDAQ:CLGN) will be releasing earnings on Wednesday, March 27, Yahoo Finance reports.
CollPlant Biotechnologies Ltd. stock logo
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 20.5% in February
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 9,400 shares, an increase of 20.5% from the February 14th total of 7,800 shares. Approximately 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 14,000 shares, the days-to-cover ratio is presently 0.7 days.
CollPlant Issues Letter to Shareholders
CollPlant Issues Letter to Shareholders
COLLPLANT BIOTECH. IS-,01 (CPT.MU)
Recap: CollPlant Biotechnologies Q3 Earnings
Get CollPlant Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

CLGN Media Mentions By Week

CLGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLGN
News Sentiment

0.00

0.45

Average
Medical
News Sentiment

CLGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLGN Articles
This Week

0

1

CLGN Articles
Average Week

Get CollPlant Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CLGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners